Search clinical trials for: GLA5PR GLARS-NF1 placebo

Total 48 results

GL Pharm Tech Corporation

Completed

Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg

Healthy

Korea, Republic of
GL Pharm Tech Corporation

Completed

Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg

Healthy

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain

Pain of Mononeuropathy

Korea, Republic of
GL Pharm Tech Corporation

Completed

A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers

Healthy
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Attention Deficit Disorder With Hyperactivity

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children

RSV Infection

United States
GL Pharm Tech Corporation

Completed

A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS-NF1 Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects

Healthy
GL Pharm Tech Corporation

Completed

A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers

Healthy

Korea, Republic of
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
GL Pharm Tech Corporation

Completed

Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS (GL2702)

Benign Prostatic Hyperplasia

Korea, Republic of
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
NFL Biosciences SAS

Completed

Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO) (PRECESTO)

Smoking Cessation | Nicotine Dependence

France
St. Joseph's Healthcare Hamilton
University Health Network, Toronto

Unknown

Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour (AHIMSA-1)

Aggression

Canada
GL Pharm Tech Corporation

Completed

PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects (GLA5PR-102)

Healthy

Korea, Republic of
NFL Biosciences SAS

Recruiting

Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy (CESTO2)

Smoking Cessation | Nicotine Dependence

France
Yale University

Completed

Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin

Type 1 Diabetes Mellitus

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Cystic Fibrosis | Bacterial Disease Carrier

United States
Brightseed

Not yet recruiting

To Evaluate the Impact of Consumption of a Bioactive Compound on Fasting Blood Glucose Levels in Asian Indians With Pre-diabetes

PreDiabetes
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Not yet recruiting

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients

Leprosy

Brazil
GlaxoSmithKline
PATH

Completed

A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies

Asthma and Rhinitis

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers

Plague

United States
Universitat Internacional de Catalunya
Dentaid SL

Completed

Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.

Dental Plaque | Side Effects

Spain
University of Sao Paulo

Completed

Fluoride Varnish X Glass Ionomer Sealant on Cervical Dentin Hypersensitivity

Dentin Sensitivity | Dentin Hypersensitivity

Brazil
EmeraMed

Recruiting

NBMI Treatment in Patients With Mercury Toxicity (NBMI-Hg-COL)

Mercury Poisoning

Colombia
Mallinckrodt ARD LLC

Terminated

A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy (BRAVE)

Muscular Dystrophy, Duchenne

Spain, Bulgaria, Italy, United States, Mexico, Israel, Serbia, Turkey
Duke University
National Institute on Aging (NIA)

Not yet recruiting

Effect of Acetylcholinesterase Inhibitors on Bone Metabolism

Osteoporosis

United States
Temple University
National Center for Complementary and Integrative Health (NCCIH); Quercegen...

Recruiting

Biological Effects of Quercetin in COPD Phase II (polyphenols)

Chronic Obstructive Pulmonary Disease | Emphysema | Chronic Bronchitis With Airway Obstruction

United States
Oregon Health and Science University

Completed

Vitamin C to Reduce Morning Cardiovascular Risk

Cardiovascular Risk Factor

United States
Instituto Nacional de Enfermedades Respiratorias
Instituto Mexicano del Seguro Social; Hospital Infantil de Mexico Federico...

Terminated

Effect of Glycine in Cystic Fibrosis

Cystic Fibrosis

Mexico
University of Sao Paulo

Completed

Non-carious Cervical Lesions and Treatments (NCCL)

Tooth Sensitivity

Brazil
Hadassah Medical Organization

Terminated

TSO in Pediatric Autistic Spectrum Disorders (TSO)

Autistic Spectrum Disorders

Israel
Cytokinetics

Completed

COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF)

Chronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | Echocardiogram

United States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
Christopher D. Verrico

Recruiting

Exenatide For Reducing the Reinforcing Effects of Cocaine

Cocaine Use Disorder

United States
Columbia University
Alliance for Better Bone Health

Completed

Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis (RPM)

Osteoporosis

United States
Yale University
Ono Pharmaceutical Co. Ltd

Withdrawn

The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications

COVID-19 | Coagulopathy | Cardiovascular Complication
Fred Hutchinson Cancer Center
Johns Hopkins University; University of Washington; Cedars-Sinai Medical Center; VA Puget Sound Health Care System and other collaborators

Completed

Effects of Sulforaphane on Normal Prostate Tissue (PHASE)

Prostate Cancer

United States
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Shire

Completed

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

Graft Rejection

United States, Germany
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Boston University
Brown University; University of Michigan; Centers for Disease Control and Prevention

Completed

Acute and Residual Effects of Caffeinated Beer

Neurobehavioral Manifestations | Alcohol Intoxication | Drug Related Sleep Disturbance

United States
Medical Center Alkmaar

Completed

Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function (EMPIRE)

Colon Cancer

Netherlands
Camillo Ricordi and Jay Skyler
Diabetes Research Institute Foundation

Not yet recruiting

Diabetes Islet Preservation Immune Treatment (DIPIT)

Autoimmune Diseases | Diabetes Mellitus | Hypoglycemia | Diabetes Mellitus, Type 1

United States
AstraZeneca

Recruiting

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma (BREATH)

Asthma, Exercise-Induced

Russian Federation
U.S. Army Medical Research and Development Command

Completed

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) (MMB4(DMS))

Safety and Efficacy

United States
Cubist Pharmaceuticals LLC

Completed

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Satheesh Elangovan

Withdrawn

Pre-Emptive Analgesia in Dental Implant Surgery

Pain, Postoperative

United States
University of Alabama at Birmingham
Congressionally Directed Medical Research Programs

Completed

Effects of Botanical Microglia Modulators in Gulf War Illness

Gulf War Illness

United States
The Faculty Hospital Na Bulovce

Completed

Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures

Small Bowel Obstruction | Acute Appendicitis | Perforated Gastroduodenal Ulcer

Czech Republic

Search clinical trials for: GLA5PR GLARS-NF1 placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations